- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 47/64 - Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
Patent holdings for IPC class A61K 47/64
Total number of patents in this class: 4970
10-year publication summary
|
91
|
199
|
311
|
563
|
650
|
724
|
696
|
788
|
709
|
192
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 18943 |
81 |
| Glaxosmithkline Biologicals S.A. | 1701 |
58 |
| Bicyclerd Limited | 130 |
58 |
| Mayo Foundation for Medical Education and Research | 2981 |
57 |
| Sarepta Therapeutics, Inc. | 353 |
48 |
| Massachusetts Institute of Technology | 9795 |
44 |
| Yale University | 2204 |
40 |
| Pfizer Inc. | 3322 |
39 |
| Purdue Research Foundation | 3277 |
39 |
| Bicycletx Limited | 149 |
38 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
34 |
| Bristol-myers Squibb Company | 5080 |
33 |
| The Board of Trustees of the Leland Stanford Junior University | 6054 |
32 |
| Sapreme Technologies B.V. | 74 |
30 |
| Northwestern University | 3112 |
27 |
| The Johns Hopkins University | 5377 |
26 |
| President and Fellows of Harvard College | 5792 |
26 |
| Ohio State Innovation Foundation | 1770 |
25 |
| Board of Regents, The University of Texas System | 5370 |
22 |
| Case Western Reserve University | 1727 |
21 |
| Other owners | 4192 |